This functional complexity underscores the importance of elucidating the precise regulatory mechanisms and context-dependent roles of EBF1 across different CRC subtypes and disease stages, particularly when considering its potential as a therapeutic target or biomarker. Here, EBF1 is linked to colorectal carcinoma.